^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
Afirma® Genomic Sequencing Classifier

Company:
Veracyte
Type:
Laboratory Developed Test
Related tests:

Details

Evidence
Afirma Genomic Sequencing Classifier (GSC) provides physicians with a comprehensive solution for a complex landscape in thyroid cancer diagnosis and individualization of care. The Afirma GSC was developed with RNA whole-transcriptome sequencing and machine learning to identify benign thyroid nodules among those deemed indeterminate by cytopathology so that these patients may avoid unnecessary surgery.
Cancer:
Thyroid Gland Medullary Carcinoma
Method:
RNA sequencing